Why FTSE 100 firm AstraZeneca’s shares fell and Codemasters’ stock soared 20% today

FTSE 100 pharma giant AstraZeneca is seeing its share price fall today, but UK gaming stock Codemasters is flying on takeover news.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 index opened, very slightly up this morning on news that Brexit negotiations will continue. This bolstered the pound, but concerns of disruption to supply chains and restrictions on UK citizens working in Europe remain. Meanwhile, in the US, hopes for a stimulus bill continue to be discussed, but nothing is yet confirmed and is still suppressing share prices.

AstraZeneca share price falls

FTSE 100 pharma giant AstraZeneca (LSE:AZN) is buying US drugmaker Alexion Pharmaceuticals in a surprise diversification away from its cancer portfolio to take a stake in rare-disease and immunology drugs. In a deal reportedly worth £29bn ($39bn), this is its largest ever transaction.

CEO Pascal Soriot has driven a turnaround in the company’s fortunes in recent years. He fought off a bid from Pfizer to buy out AstraZeneca back in 2014 and has worked hard to develop a ground-breaking set of cancer drugs.

The AstraZeneca share price has therefore steadily risen over the past two years. It was also encouraged this year by its involvement in creating a Covid-19 vaccine in collaboration with Oxford University. This has been largely successful. It’s coming in cheaper and more logistically viable than Pfizer’s offering, but still must get through some final testing hurdles.

In light of its buoyant share price, the CEO wants to add value by increasing market share. This is the reason for the mega purchase of Alexion. Nevertheless, some shareholders don’t see the value and that’s why the FTSE 100 company’s share price fell almost 7% at the opening bell.

The CEO believes this acquisition will increase earnings per share, which in turn will help to justify its massive price-to-earnings ratio (P/E) of 99. AstraZeneca offers shareholders a 2.7% dividend yield.

Codemasters to be bought by Electronic Arts

Meanwhile, shares in AIM-listed Codemasters Group Holdings (LSE:CDM) jumped over 20% this morning. This was on the back of weekend news that Electronic Arts wants to buy it. NASDAQ-listed Electronic Arts has a market cap of £30bn ($40bn) and P/E of 30. The massive US computer games company has agreed to buy Codemasters for £945m ($1.2bn).

This was after outbidding rival US company Take-Two Interactive Software. The maker of Grand Theft Auto had offered £759m ($1bn) in a cash-and-stock deal. The Codemasters share price is up 82% since Take Two first made its bid in September.

Codemasters’ ongoing success largely comes from the popularity of its racing simulator games, including Formula One, Project Cars and Dirt. Leading video games publisher Electronic Arts, on the other hand, makes Fifa, Apex Legends, Battlefield, Need for Speed, Star Wars and many more.

The Codemasters share price has now risen 129% year-to-date. It’s also up 222% since the 30-year-old company publicly listed in 2018. Tech and gaming companies are particularly popular at the moment and have done very well in 2020. This is spurring the drive for big gaming companies to snap up promising smaller entities. Investing in tech and health companies remains popular among retail investors despite skyrocketing valuations and concerns of a bubble in the tech sector.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kirsteen has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Take-Two Interactive. The Motley Fool UK has recommended Electronic Arts. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »